By Associate Professor Stuart Grant Turville

Journal articles

Sloane AJ; Raso V; Dimitrov DS; Xiao X; Deo S; Muljadi N; Restuccia D; Turville S; Kearney C; Broder CC; Zoellner H; Cunningham AL; Bendall L; Lynch GW, 2005, 'Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-1α responses', Immunology and Cell Biology, 83, pp. 129 - 143, http://dx.doi.org/10.1111/j.1440-1711.2004.01304.x

Turville SG; Santos JJ; Frank I; Cameron PU; Wilkinson J; Miranda-Saksena M; Dable J; Stõssel H; Romani N; Piatak M; Lifson JD; Pope M; Cunningham AL, 2004, 'Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells', Blood, 103, pp. 2170 - 2179, http://dx.doi.org/10.1182/blood-2003-09-3129

Turville S; Wilkinson J; Cameron P; Dable J; Cunningham AL, 2003, 'The role of dendritic cell C-type lectin receptors in HIV pathogenesis', Journal of Leukocyte Biology, 74, pp. 710 - 718, http://dx.doi.org/10.1189/jlb.0503208

Lynch GW; Slaytor EK; Elliott FD; Saurajen A; Turville SG; Sloane AJ; Cameron PU; Cunningham AL; Halliday GM, 2003, 'CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers', Experimental Dermatology, 12, pp. 700 - 711, http://dx.doi.org/10.1034/j.1600-0625.2003.00078.x

Kedzierska K; Crowe SM; Turville S; Cunningham AL, 2003, 'The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages', Reviews in Medical Virology, 13, pp. 39 - 56, http://dx.doi.org/10.1002/rmv.369

Turville SG; Cameron PU; Derek H; Cunningham AL, 2002, 'C-type lectin-HIV attachment on dendritic cells:Innate immune recognition and processing or mediators of HIV transmission?', Trends in Glycoscience and Glycotechnology, 14, pp. 255 - 271, http://dx.doi.org/10.4052/tigg.14.255

Turville SG; Cameron PU; Handley A; Lin G; Pöhlmann S; Doms RW; Cunningham AL, 2002, 'Diversity of receptors binding HIV on dendritic cell subsets', Nature Immunology, 3, pp. 975 - 983, http://dx.doi.org/10.1038/ni841

Turville SG; Arthos J; MacDonald K; Lynch G; Naif H; Clark G; Hart D; Cunningham AL, 2001, 'HIV gp120 receptors on human dendritic cells', Blood, 98, pp. 2482 - 2488, http://dx.doi.org/10.1182/blood.V98.8.2482

Turville SG; Cameron PU; Arthos J; MacDonald K; Clark G; Hart D; Cunningham AL, 2000, 'Sweet symphony', New Scientist, 166, pp. 11

Conference Papers

Cunningham A; Wilkinson J; Turville S; Bosnjak L; Dable J; Lai J; Nicolle M, 2005, 'Interaction of human epithelial dendritic cells with HIV and Herpes Simplex virus', in TISSUE ANTIGENS, BLACKWELL PUBLISHING, AUSTRALIA, Melbourne, pp. 387 - 388, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, AUSTRALIA, Melbourne, 29 November 2005 - 02 December 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Czuba-Wojnilowicz E; Klemm V; Cortez-Jugo C; Turville S; Aggarwal A; Caruso F; Kelleher AD; Ahlenstiel CL, 2023, 'Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types', in Molecular Pharmaceutics, Vol. 20, pp. 2039 - 2052, http://dx.doi.org/10.1021/acs.molpharmaceut.2c01030

Segelov E; Body A; Luong V; Lopez VA; Lal L; Abdulla H; Turville S; Niang Z; Opat S; McCuaig R; Lineburg K; Rao S; Smith C; MacIntyre R; Ahern E, 2022, 'Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract', in Cancer Research, American Association for Cancer Research (AACR), Vol. 82, pp. CT259 - CT259, http://dx.doi.org/10.1158/1538-7445.am2022-ct259

Segelov E; Body A; Turville S; Smith C; Lineburg K; Rao S; McCuaig R; Opat S; Niang Z; Lal L; Luong V; Abdulla H; Lopez VA; Padhye B; Bolanos NF; Anazodo A; MacIntyre R; Downie P; O'Brien T; Ahern E, 2022, 'Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET', in Cancer Research, American Association for Cancer Research (AACR), Vol. 82, pp. ct567 - ct567, http://dx.doi.org/10.1158/1538-7445.am2022-ct567

Segelov E; Body A; Luong VTT; Aedo Lopez V; Lal L; Abdulla H; Turville S; Naing Z; Opat S; McCuaig R; Rao S; Lineburg K; Smith C; MacIntyre C; Ahern ES, 2022, 'Humoral and cellular immune response to Sars-CoV-2 wild-type and variants of concern following 3-dose vaccination in a large cohort of adults with cancer: The SerOzNET study.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. LBA12065 - LBA12065, http://dx.doi.org/10.1200/jco.2022.40.17_suppl.lba12065

Body A; Ahern E; Abdulla H; Lal L; Turville S; Naing Z; Opat S; Leahy M; Hamad N; Lineburg K; Smith C; McCuaig R; Rao S; McIntyre R; Fuentes-Bolanos N; Padhye B; Busija L; Downie P; Milch V; Segelov E, 2022, 'Immune response to COVID-19 vaccination in adults and children with cancer: results from the prospective SerOzNET study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 91 - 91

Klemm V; Czuba-Wojnilowicz EI; Cortez-Jugo C; Turville SG; Caruso F; Kelleher AD; Ahlenstiel CL, 2020, 'Delivering Epigenetic Silencing Sirna to the Nucleus of Hiv-1 Infected Primary Activated Cd4+T-Cells via Nanoparticle System', in MOLECULAR THERAPY, CELL PRESS, ELECTR NETWORK, Vol. 28, pp. 468 - 469, presented at 23rd Annual Meeting of the American-Society-for-Gene-and-Cell-Therapy, ELECTR NETWORK, 12 May 2020 - 15 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530089302176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Y; Bailey M; Phetsouphanh C; Harvey R; Turville S; Aggarwal A; Wong A; Suzuki K; Graff-Dubois S; Autran B; Moris A; Munier ML; Koelsch K; Kent S; Zaunders J; Kelleher A, 2016, 'Accumulation of follicular T Helper (Tfh) cells, despite preferential infection, allows establishment of a large and unexpected viral reservoir during HIV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 264 - 264, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168

Working Papers

Capraro A; Wong SL; Adhikari A; Allan KM; Patel HR; Zhong L; Raftery M; Jaffe A; Yeang M; Aggarwal A; Wu L; Pandzic E; Whan RM; Turville S; Vittorio O; Bull RA; Kaakoush N; Rawlinson WD; Tedla N; Vafaee F; Waters SA, Ageing impairs the airway epithelium defence response to SARS-CoV-2, Cold Spring Harbor Laboratory, http://dx.doi.org10.1101/2021.04.05.437453

Preprints

Turville S, 2025, Replication of SARS-CoV-2 Omicron lineages is defined by TMPRSS2 use in environments where ACE2 is complexed with solute carriers SLC6A19 and SLC6A20., http://dx.doi.org/10.21203/rs.3.rs-7065324/v1

Aggarwal A; Ognenovska S; Ison T; Fichter C; Milogiannakis V; Afzal M; Stella AO; Waters S; Esneau C; Bartlett N; Pöhlmann S; Hoffmann M; Burrell L; Patel S; Ellis S; Wehrhahn M; Martinez E; Ginn A; Churchill M; Angelovich T; Rawlinson W; Yeang M; Kok J; Sintchenkov V; Parry R; Sng J; Neely G; Moreno C; Loo L; Kelleher A; Brilot F; Khromykh A; Turville S, 2025, Replication of SARS-CoV-2 Omicron lineages is defined by TMPRSS2 use in environments where ACE2 is complexed with solute carriers SLC6A19 and SLC6A20, http://dx.doi.org/10.1101/2025.07.07.663433

Perkins G; Hope C; Chai CS; Tunbridge M; Sterling S; Webb K; Yap J; Yeow AEL; Masavuli M; Kireta S; Zuiani J; Akerman A; Aggarwal A; Milogiannakis V; Roberts M; Wilson W; Hurtado P; Turville S; Grubor-Bauk B; Barry S; Coates T; Ravindran J; Hissaria P, 2023, Immune profiling of COVID-19 vaccine responses in people with multiple sclerosis on B cell-depleting therapy, http://dx.doi.org/10.1101/2023.12.04.23299409

Thijssen V; Hurdiss DL; Debski-Antoniak OJ; Spence MA; Franck C; Norman A; Aggarwal A; Mokiem NJ; van Dongen DAA; Vermeir SW; Liu M; Li W; Chatziandreou M; Donselaar T; Du W; Drulyte I; Bosch B-J; Snijder J; Turville S; Payne RJ; Jackson CJ; van Kuppeveld FJM; Jongkees SAK, 2022, A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein, http://dx.doi.org/10.1101/2022.11.11.516114

Akerman A; Milogiannakis V; Jean T; Esneu C; Silva MR; Ison T; Fitcher C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster C; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Sandgren KJ; Bull RA; Lloyd AR; Triccas J; Tangye SG; Bartlett NW; Darley DR; Matthews G; Starck D; Rawlinson W; Brilot F; Cunningham AL; Kelleher A; Aggarwal A; Turville S, 2022, Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level, http://dx.doi.org/10.2139/ssrn.4295993

Poumbourios P; Langer C; Boo I; Zakir T; Center R; Akerman A; Milogiannakis V; Aggarwal A; Turville S; Drummer H, 2022, Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core, http://dx.doi.org/10.1101/2022.11.08.515567

Aggarwal A; Stella A; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Lenthall H; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fitcher C; Hoppe AC; Munier CML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2022, SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, http://dx.doi.org/10.21203/rs.3.rs-1207364/v1

Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson S; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer D; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2021, Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses, http://dx.doi.org/10.2139/ssrn.3920641

Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd AR; Martinello M; Bull RA; Group CS, 2020, Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2, http://dx.doi.org/10.2139/ssrn.3732365

Wong AKH; Mathivanan V; Di Giallonardo F; Ahlenstiel C; Turville SG, 2019, A Molecular Basis for the Increased Transmission of Ebolavirus in Recent Outbreaks, http://dx.doi.org/10.2139/ssrn.3507710

Counoupas C; Johansen MD; Stella AO; Nguyen DH; Ferguson AL; Aggarwal A; Bhattacharyya ND; Grey A; Patel K; Siddiquee R; Stewart EL; Feng CG; Hansbro NG; Palendira U; Steain MC; Saunders BM; Low JKK; Mackay JP; Kelleher AD; Britton WJ; Turville SG; Hansbro PM; Triccas JA, A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilizing immunity against SARS-CoV-2 infection in mice, http://dx.doi.org/10.1101/2020.12.10.419044

Rouet R; Henry JY; Johansen MD; Sobti M; Balachandran H; Langley DB; Walker G; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett DL; Brown SHJ; Martinello M; Hudson B; Gilroy N; Post JJ; Kelleher A; Jäck H-M; Goodnow CC; Turville SG; Rawlinson WD; Bull RA; Stewart AG; Hansbro PM; Christ D, Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients, http://dx.doi.org/10.1101/2022.10.19.512954

Garcia-Valtanen P; Hope CM; Masavuli MG; Yeow AEL; Balachandran H; Mekonnen ZA; Al-Delfi Z; Abayasingam A; Agapiou D; Stella AO; Aggarwal A; Gummow J; Ferguson C; O’Connor S; McCartney EM; Lynn DJ; Maddern G; Gowans EJ; Reddi BA; Shaw D; Kok-Lim C; Turville SG; Beard MR; Weiskopf D; Sette A; Bull RA; Barry SC; Grubor-Bauk B, COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection, http://dx.doi.org/10.1101/2021.11.08.21266035

Shen Y; Freeman JA; Holland J; Solterbeck A; Naidu K; Soosapilla A; Downe P; Tang C; Kerridge I; Wallman L; Van Bilsen N; Milogiannakis V; Akerman A; Gomes GMC; Sandgren K; Cunningham AL; Turville S; Mulligan SP, COVID-19 Vaccine Failure in Chronic Lymphocytic Leukemia and Monoclonal B-Lymphocytosis; Humoral and Cellular Immunity, http://dx.doi.org/10.1101/2021.10.28.21265549

Johansen-Leete J; Ullrich S; Fry SE; Frkic R; Bedding MJ; Aggarwal A; Ashhurst AS; Ekanayake KB; Mahawaththa MC; Sasi VM; Passioura T; Larance M; Otting G; Turville S; Jackson CJ; Nitsche C; Payne RJ, Discovery of Antiviral Cyclic Peptides Targeting the Main Protease of SARS-CoV-2 via mRNA Display, http://dx.doi.org/10.1101/2021.08.23.457419

Norman A; Franck C; Christie M; Hawkins PME; Patel K; Ashhurst AS; Aggarwal A; Low JKK; Siddiquee R; Ashley CL; Steain M; Triccas JA; Turville S; Mackay JP; Passioura T; Payne RJ, Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein using mRNA Display, http://dx.doi.org/10.1101/2020.12.22.424069

Lee WS; Tan H-X; Reynaldi A; Esterbauer R; Koutsakos M; Nguyen J; Amarasena T; Kent HE; Aggarwal A; Turville SG; Taiaroa G; Kinsella P; Liew KC; Tran T; Williamson DA; Cromer D; Davenport MP; Kent SJ; Juno JA; Khoury DS; Wheatley AK, Durable reprogramming of neutralising antibody responses following breakthrough Omicron infection, http://dx.doi.org/10.1101/2023.02.19.23286159

Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fitcher C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; More AMV; Hunt S; Douglas M; Caterson I; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level, http://dx.doi.org/10.1101/2022.12.06.22283000

Loo L; Waller MA; Moreno CL; Cole AJ; Stella AO; Pop O-T; Jochum A-K; Ali OH; Denes CE; Hamoudi Z; Chung F; Aggarwal A; Low JKK; Patel K; Siddiquee R; Kang T; Mathivanan S; Mackay JP; Flatz L; Hesselson D; Turville S; Neely GG, Fibroblast-expressed LRRC15 suppresses SARS-CoV-2 infection and controls antiviral and antifibrotic transcriptional programs, http://dx.doi.org/10.1101/2021.11.09.467981

Lau D; Walsh J; Peng W; Shah V; Turville S; Jacques D; Böcking T, Fluorescence biosensor for real-time interaction dynamics of host proteins with HIV-1 capsid tubes, http://dx.doi.org/10.1101/619841

Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells, http://dx.doi.org/10.1101/2022.07.22.22277947

Langer C; Boo I; Zakir T; Mackenzie-Kludas C; Samuel J; Fabb SA; Lee CL; Center RJ; Aggarwal A; Turville S; Pouton C; Subbarao K; Coulibaly F; Drummer HE; Poumbourios P, High-stability, clamp-free soluble Sarbecovirus spike trimers and their potential for pan-Sarbecovirus vaccine development, http://dx.doi.org/10.1101/2025.09.14.676173

Aggarwal A; Stella AO; Henry C; Narayan K; Turville SG, HIV corruption of the Arp2/3-Cdc42-IQGAP1 axis to hijack cortical F-Actin to promote cell-cell viral spread, http://dx.doi.org/10.1101/2019.12.13.873612

Dor G; Kekana D; Hisner R; Martin DP; Korber B; Ernst T; Levy A; Speers D; Turville S; Sintchenko V; Basile K; Sullivan G; Rockett R; Kok J; Gueli F; Lessels R; Baxter C; Wolter N; von Gottberg A; Tegally H; de Oliveira T, Identification and genomic characterisation of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa, http://dx.doi.org/10.64898/2025.12.19.25342658

Li L; Honda-Okubo Y; Huang Y; Jang H; Carlock MA; Baldwin J; Piplani S; Bebin-Blackwell AG; Forgacs D; Sakamoto K; Stella A; Turville S; Chataway T; Colella A; Triccas J; Ross TM; Petrovsky N, Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection, http://dx.doi.org/10.1101/2021.07.03.451026

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJ; Wilson DB; Manandhar B; Klemm V; Tan H-X; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, Improvement of immune dysregulation and health-related quality of life in individuals with long COVID at 24-months following SARS-CoV-2 infection, http://dx.doi.org/10.1101/2023.08.27.23294704

Pillay A; Yeola A; Tea F; Denkova M; Houston S; Burrell R; Merheb V; Lee FXZ; Moran L; Jadhav A; Sterling K; Lai CL; Vitagliano TL; Aggarwal A; Catchpoole D; Wood N; Phan TG; Nanan R; Hsu P; Turville SG; Britton PN; Brilot F, Infection and vaccine induced Spike antibody responses against SARS-CoV-2 Variants of concern in immune naïve children and adults, http://dx.doi.org/10.21203/rs.3.rs-2262275/v1

Bull R; Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post J; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd A; Martinello M, Long-term persistence of neutralizing memory B cells in SARS-CoV-2, http://dx.doi.org/10.21203/rs.3.rs-92527/v1

Foster CSP; Walker GJ; Jean T; Wong M; Brassil L; Isaacs SR; Lyu Y; Turville S; Kelleher A; Rawlinson WD, Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution, http://dx.doi.org/10.1101/2023.11.02.565396

Loo L; Waller M; Cole A; Stella A; Moreno C; Denes C; Hamoudi Z; Chung F; Aggarwal A; Low J; Patel K; Siddiquee R; Mackay J; Turville S; Hesselson D; Neely G, LRRC15 suppresses SARS-CoV-2 infection and controls collagen production, http://dx.doi.org/10.21203/rs.3.rs-1172665/v1

Perkins GB; Tunbridge MJ; Chai CS; Hope CM; Yeow AEL; Salehi T; Singer J; Shi B; Masavuli MG; Mekonnen ZA; Garcia-Valtanen P; Kireta S; Johnston JK; Drogemuller CJ; Sim BZ; Spencer SM; Sallustio BC; Comerford I; Bouras G; Weiskopf D; Sette A; Aggarwal A; Milogiannakis V; Akerman A; Turville S; Hurtado PR; Ying T; Hissaria P; Barry SC; Chadban SJ; Grubor-Bauk B; Coates PT, mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients, http://dx.doi.org/10.1101/2023.03.27.23287773

Back to profile page